Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447697A Antitumor effect potentiators
10/08/2003CN1447696A Gene detection assay for improving likelihood of effective response to erbb antagonist cancer therapy
10/08/2003CN1447695A Potent immunostimulants from microalgae
10/08/2003CN1447692A Methods of drug delivergy to hepatocytes and treatment of flaviviridae infections
10/08/2003CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1447688A Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
10/08/2003CN1447686A D-Enantiomer of DFMO and methods of use thereof for treating cancer
10/08/2003CN1447685A Process for decreasing cell proliferation based on (3R,4R)-Ôû�8-tetrahydrocannabinol)-11-acid
10/08/2003CN1447683A Polymeric micelle compsns.
10/08/2003CN1446818A Technique of preparing extract product of ÔÇÿLiangtoujianÔÇÖ and its application in preparing medication of treating cancer
10/08/2003CN1446814A Method for preparing psoralen and isopsoralen
10/08/2003CN1446809A Derivant of new type sweetsop lactone as well as preparation method and usage
10/08/2003CN1446785A Method of producing magnolol and honokiol
10/08/2003CN1446585A Combination object of half solid framework preparation of gingko leaf extract product
10/08/2003CN1446583A Composition, preparation and application scheme of tumor immunological therapy and preventative vaccine
10/08/2003CN1446564A Chinese herbal medicine for accessorial treating cancer and its preparing method
10/08/2003CN1446543A Sea cucumber polysaccharide preparation
10/08/2003CN1446452A Method for grafting tree species capable of extracting anticancer drugs
10/08/2003CN1123577C Ocean thalassiomycete hypoxylon polyose and its extracting process and application
10/08/2003CN1123574C Ligands for FLT3 receptors
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CN1123346C Animal cartilage health-care capsule for inhibiting tumour growth, eliminating free radical and anti peroxidation of lipid and prepn. method thereof
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003US6630579 Complex
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630501 Phosphinic pseudo-peptides that may be used as matrix zinc metalloprotease inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630484 6-and 7-substituted analogs of swainsonine their preparation and therapeutic use
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630464 Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630454 Method and pharmaceutical composition for the treatment of cancer
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630173 Mixture with antiproliferative agent
10/07/2003US6630168 Dimethylacetamide in combination with methyl cellulose, hydroxypropyl methylcellulose, or carboxypolymethylene; intralesional administering
10/07/2003US6630128 Insoluble support
10/07/2003US6630124 Combination therapy with VIP antagonist
10/07/2003US6630120 Co-administering intravascularly a bradykinin agonist that increases the transport of said substance from the bloodstream to the internal spaces of said non-central nervous system solid tumor
10/07/2003US6629995 Camptothecin conjugates
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2258146C Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080841A1 Calcineurin activators
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080817A1 Process for producing cytotoxic lymphocyte
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080642A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring
10/02/2003WO2003080641A1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080624A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
10/02/2003WO2003080620A1 Inhibitors of nucleoside phosphorylases and nucleosidases
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080171A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
10/02/2003WO2003080122A1 Method and agent for producing therapeutically active blood compositions
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080111A2 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080083A1 Use of adenoviruses mutated in the va genes for cancer treatment
10/02/2003WO2003080077A1 Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination
10/02/2003WO2003080076A1 Novel therapeutic use of riboside of 5-aminoimidazole-4- carboxamide (acadesine)
10/02/2003WO2003080075A1 Ameliorant for chemical treatment of cancer
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080049A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003WO2003080048A1 (-)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
1 ... 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 ... 2211